share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Aug 6 16:54

Summary by Moomoo AI

Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company on 08/06/2024, as per the latest filing. These shares, valued at approximately $78,083.44, were originally acquired on 09/01/2016 as founders shares and as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $694,221.07.
Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company on 08/06/2024, as per the latest filing. These shares, valued at approximately $78,083.44, were originally acquired on 09/01/2016 as founders shares and as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $694,221.07.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more